Suchbegriff: Outlook Therapeutics in Rubrik News
ResMed Inc (ISIN: US75102W1036) a leader in sleep apnea ...
ResMed Inc stock faces pressure amid slowing sleep apnea device demand and insurance reimbursement headwinds
ad-hoc-news.de, 25.03.26 14:27 UhrVirbac S.A. (ISIN: FR0000031577) the French veterinary pharmaceutical ...
Virbac S.A. stock faces pressure after Q1 miss but analysts see limited long-term impact
ad-hoc-news.de, 25.03.26 00:21 UhrBachem Holding AG (ISIN: CH0012530207) the Swiss peptide ...
Bachem Holding AG stock faces operational push amid peptide market expansion and biotech demand surge
ad-hoc-news.de, 24.03.26 23:08 UhrThe Galenica AG stock (ISIN: CH0025536027) Switzerland's ...
Galenica AG stock faces valuation scrutiny as P/E ratio hits 24.3x amid Swiss pharma retail shifts
ad-hoc-news.de, 24.03.26 20:11 UhrAgilent Technologies Inc. (ISIN: US00846U1016) has launched ...
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting life sciences growth prospects
ad-hoc-news.de, 24.03.26 20:07 UhrDie Vertex Pharmaceuticals Aktie (ISIN: US92532F1003) zeigt ...
Vertex Pharma Aktie: Stabile Biotech-Position trotz Marktschwäche und leichter Kursrückgänge
ad-hoc-news.de, 23.03.26 13:27 Uhr¿Estás siguiendo las acciones de Ryvu Therapeutics S.A.? ...
¡Ryvu Therapeutics publica resultados del 4T 2025 con EBITDA superando expectativas! ¿Qué significa para inversores en Alemania?
ad-hoc-news.de, 20.03.26 18:21 UhrVYNE Therapeutics (ISIN: US92941V1008) shares climbed 6.82% ...
VYNE Therapeutics stock rises amid biotech volatility and merger talks
ad-hoc-news.de, 20.03.26 15:13 UhrInhibrx Inc (ISIN: US45720L1070) released fourth quarter ...
Inhibrx Inc stock surges on Q4 2025 earnings and key 2026 pipeline milestones
ad-hoc-news.de, 20.03.26 14:59 UhrHalozyme Therapeutics (ISIN: US40637H1095) released Q4 and ...
Halozyme Therapeutics stock faces pressure after Q4 earnings amid biotech volatility
ad-hoc-news.de, 20.03.26 14:41 UhrDie Novartis AG Aktie (ISIN: CH0012005267) notiert resilient ...
Novartis AG Aktie (ISIN: CH0012005267) hält sich stabil trotz gemischter Signale
ad-hoc-news.de, 15.03.26 23:59 UhrDie Bewertung von Outlook Therapeutics hängt von regulatorischen ...
Outlook Therapeutics Aktie: Meilensteine im Blick
boerse-global.de, 10.03.26 06:14 UhrOutlook Therapeutics Aktie: Doppelte Belastung
boerse-global.de, 19.02.26 08:58 UhrOutlook Therapeutics US69012T2069
Outlook Therapeutics Aktie: Doppelte Belastung
boerse-global.de, 19.02.26 08:58 UhrVertex Pharmaceuticals’ cystic fibrosis blockbuster Trikafta ...
Vertex Pharma’s Cystic Fibrosis Franchise: How Trikafta Powers the Pipeline — and the Stock
ad-hoc-news.de, 29.12.25 07:40 UhrTechnical Indicators Flash Warning Signal
Perspective Therapeutics Charts New Course with CFO Appointment Amid Technical Concerns
boerse-global.de, 06.09.25 07:45 UhrXORTX gibt Neueinreichung der MD&A-Unterlagen für das Geschäftsjahr ...
